US › Healthcare

cbdMD Inc (YCBD)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.56-2.02%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$5.6M

Revenue YoY

+18.8%

Net profit

$-797,978

Profit YoY

-66.0%

EPS

$-0.08

EPS estimate

$-0.05

Net margin

-14.1%

EPS came in at -0.08 against a street estimate of -0.05 — a miss of 60.0%.

Key statistics

Market cap

$5.3M

P/E

0.2

Forward P/E

714.3

P/B

0.57

Book value

$0.88

EPS (TTM)

$2.46

52-week high

$2.56

52-week low

$0.47

50-day MA

$0.68

200-day MA

$0.83

Beta

2.13

Analyst view

Analysts rate cbdMD Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $2.00.

Shareholding

Insiders

10.68%

Institutions

9.58%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for cbdMD Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.